0 38

Cited 0 times in

Clinical characteristics of super stable polypoidal choroidal vasculopathy after initial remission with anti-VEGF monotherapy

DC Field Value Language
dc.contributor.author최성희-
dc.contributor.author고형준-
dc.date.accessioned2022-11-24T00:46:57Z-
dc.date.available2022-11-24T00:46:57Z-
dc.date.issued2021-04-
dc.identifier.issn0721-832X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/190970-
dc.description.abstractPurpose: To define a "super stable" subset of polypoidal choroidal vasculopathy (PCV) patients that have a long period of remission following anti-vascular endothelial growth factor (VEGF) therapy. Methods: Twenty-one eyes that showed no recurrence for over 18 months following anti-VEGF monotherapy were included in the "super stable PCV group" and compared with 37 eyes with recurring disease. Patient demographics, visual acuity, and imaging data from optical coherence tomography (OCT) and fluorescein angiography/indocyanine green angiography were compared between the two groups at baseline and at 3 months after treatment initiation. Results: The super stable group maintained remission for a mean duration of 31.0 months following a mean of 4.1 anti-VEGF injections. The super stable group was younger at baseline (64.6 ± 8.8 vs. 71.4 ± 7.9 years, P < 0.05) with a higher ratio of females (52.4% vs. 24.3%, P < 0.05) compared with the control group. The super stable group had a higher percentage of eyes with a single polyp, as opposed to multiple polyps (66.7% vs. 32.4%, P < 0.05), and the diameter of the largest polyp was smaller (328.4 ± 98.2 vs. 398.3 ± 112.2 μm, P < 0.05). Baseline choroidal thickness was greater in the super stable group (357 ± 102.7 vs. 293.2 ± 94.6 μm, P < 0.05). At 3 months after treatment, OCT features including central retinal thickness, pigment epithelial detachment (PED) size, and presence of subretinal fluid showed superior response in the super stable group. The reduction in PED height was almost 3 times as large in the super stable group (- 250.1 ± 228.5 μm vs. - 84.4 ± 221.1 μm, P < 0.05). Binary logistic regression further showed that factors such as age, polyp configuration, PED diameter at 3 months, and change in PED height at 3 months were associated with super stable remission. Conclusion: Identifying super stable PCV patients can prevent overtreatment and lessen treatment burden.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish, German-
dc.publisherSpringer-Verlag-
dc.relation.isPartOfGRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAngiogenesis Inhibitors / therapeutic use-
dc.subject.MESHChoroid-
dc.subject.MESHChoroidal Neovascularization* / diagnosis-
dc.subject.MESHChoroidal Neovascularization* / drug therapy-
dc.subject.MESHFemale-
dc.subject.MESHFluorescein Angiography-
dc.subject.MESHHumans-
dc.subject.MESHInfant-
dc.subject.MESHIntravitreal Injections-
dc.subject.MESHPolyps* / diagnosis-
dc.subject.MESHPolyps* / drug therapy-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHTomography, Optical Coherence-
dc.subject.MESHVascular Endothelial Growth Factor A-
dc.titleClinical characteristics of super stable polypoidal choroidal vasculopathy after initial remission with anti-VEGF monotherapy-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Ophthalmology (안과학교실)-
dc.contributor.googleauthorSeonghee Choi-
dc.contributor.googleauthorHae Min Kang-
dc.contributor.googleauthorHyoung Jun Koh-
dc.identifier.doi10.1007/s00417-020-04924-0-
dc.contributor.localIdA05867-
dc.contributor.localIdA00152-
dc.relation.journalcodeJ00951-
dc.identifier.eissn1435-702X-
dc.identifier.pmid33245428-
dc.identifier.urlhttps://link.springer.com/article/10.1007/s00417-020-04924-0-
dc.subject.keywordAge-related macular degeneration-
dc.subject.keywordAnti-VEGF-
dc.subject.keywordPolypoidal choroidal vasculopathy-
dc.contributor.alternativeNameChoi, Seonghee-
dc.contributor.affiliatedAuthor최성희-
dc.contributor.affiliatedAuthor고형준-
dc.citation.volume259-
dc.citation.number4-
dc.citation.startPage837-
dc.citation.endPage846-
dc.identifier.bibliographicCitationGRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, Vol.259(4) : 837-846, 2021-04-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.